The Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AI

Personalized cancer vaccines are creating a diagnostics investment opportunity beyond Moderna and Merck, with tumor sequencing at its center. The post The Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AI appeared first on BeInCrypto.